Delivery Order SPE2DB22D2007-SPE2DB25FJ4YH
- Not listed
- The Defense Logistics Agency awarded a $15,848.80 delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, with an ultimate completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,754.64 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials. This award, issued on August 22, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of September 15, 2025. The contract is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,924.40 on August 5, 2025, for the supply of Veklury 100 mg vials, an antiviral medication used in treating severe respiratory infections. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, valued at $7,924.40 under a firm fixed price contract type. This competitively awarded, non-set-aside delivery order has an ultimate completion date of September 16, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $11,886.30 to AmerisourceBergen Drug Corp for the supply of Veklury 100 mg vials, a critical antiviral medication. The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of September 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $3,962.20 delivery order to AmerisourceBergen Drug Corp on May 22, 2025, for the supply of Veklury 100 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location in Conshohocken, PA 19428....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $15,848.80 and a firm fixed price contract structure. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Veklury 100 mg vials, with a ceiling value of $7,924.40. This firm fixed-price delivery order, which is a child contract under a larger vehicle, is scheduled for completion by September 11, 2025, with performance occurring at the awardee's facility in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation,...
- This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order, valued at $6,809.20, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4YHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,848.80 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Veklury 100 mg vials, with an ultimate completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The company will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. The prime contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive award processes and maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 9/15/25 |